Of these, 26 patients with Fabry’s disease presented with signs of cardiomyopathy, such as left ventricular hypertrophy combined with elevated serum markers of NTproBNP and/or hsTNT and/or positive LGE in CMR. This evidence concerns the gene NPPB and left ventricular hypertrophy.